NCM
STTK icon

NEXTBio Capital Management’s Shattuck Labs STTK Stock Holding History

NEXTBio Capital Management’s Portfolio STTK Stock Details STTK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$25.9M Buy
3,727,348
+577,441
+18% +$3.6M 11.9% 2
2026
Q1 		$20.3M Hold
3,149,907
– – 9.4% 3
2025
Q4 		$11.5M Buy
+3,149,907
New +$7.52M 6.74% 5

Other funds holding STTK

T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.49B AUM 208.7% 1-Year Est. Return
O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
PM
Prosight Management Dallas, Texas $580M AUM 29.81% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
FLSM
Frazier Life Sciences Management Palo Alto, California $4.59B AUM 237.58% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

NEXTBio Capital Management's STTK Position: Q2 2026 in Review

NEXTBio Capital Management increased its Shattuck Labs (STTK) stake by 18% in Q2 2026, buying an estimated $3.6M and bringing the position to 3,727,348 shares worth $25.9M. The position accounts for 11.9% of the portfolio, ranked #2.

NEXTBio Capital Management first reported a position in STTK in Q4 2025 and has held it in 3 quarters since. 100 funds tracked by Wall St. Rank hold STTK as of Q2 2026.

  • NEXTBio Capital Management held 3,727,348 shares of Shattuck Labs worth $25.9M as of Q2 2026.
  • NEXTBio Capital Management bought 577,441 Shattuck Labs shares in Q2 2026, an estimated $3.6M.
  • Shattuck Labs made up 11.9% of NEXTBio Capital Management's portfolio in Q2 2026, its #2 holding.
  • NEXTBio Capital Management first reported a position in Shattuck Labs in Q4 2025 and has held it in 3 quarters since.
  • 100 funds tracked by Wall St. Rank held Shattuck Labs as of Q2 2026.

Based on NEXTBio Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.